MedTrace Logo

A Trial of Hetrombopag in Healthy Subjects

NCT05088174 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2021-10-21

No results posted yet for this study

Summary

This is a single-center, single-arm, open-label, self-controlled, phase I clinical study. A total of 26 male or female healthy subjects are intended to be enrolled to evaluate the PK drug-drug interaction between ciclosporin and hetrombopag.

Conditions

  • Sever Aplastic Anaemia

Interventions

DRUG

Hetrombopag Olamine Tablet；Ciclosporin Soft Capsule

Drug: Hetrombopag Olamine Tablet Ciclosporin Soft Capsule

Sponsors & Collaborators

  • Jiangsu HengRui Medicine Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-03
Primary Completion
2020-10-22
Completion
2020-10-22

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05088174 on ClinicalTrials.gov